T Cell Antigen Receptor Ubiquitination Is a Consequence of Receptor-mediated Tyrosine Kinase Activation (*)

Engagement of the T cell antigen receptor results in both its phosphorylation and its ubiquitination. T cell antigen receptor ubiquitination was evaluated in Jurkat, a well characterized human T leukemia cell line. Treatment of cells with the tyrosine kinase inhibitor herbimycin A resulted in an inhibition of receptor ubiquitination. Consistent with this, pervanadate, which increases cellular tyrosine phosphorylation, enhanced receptor ubiquitination. A requirement for receptor-mediated tyrosine kinase activity for ubiquitination was confirmed in cells lacking the tyrosine kinase p56 and also in cells that are defective in expression of CD45, a tyrosine phosphatase that regulates the activity of p56. The need for tyrosine kinase activation for ubiquitination was not bypassed by directly activating protein kinase C and stimulating endocytosis of receptors. These observations establish ubiquitination of the T cell antigen receptor as a tyrosine kinase-dependent manifestation of transmembrane signaling and suggest a role for tyrosine phosphorylation in the ligand-dependent ubiquitination of mammalian transmembrane receptors.

[1]  S. Mori.  [Ligand-induced polyubiquitination of receptor tyrosine kinases]. , 1995, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme.

[2]  A. Ciechanover,et al.  Stimulation-dependent I kappa B alpha phosphorylation marks the NF-kappa B inhibitor for degradation via the ubiquitin-proteasome pathway. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[3]  A. Hershko,et al.  Reversible phosphorylation controls the activity of cyclosome-associated cyclin-ubiquitin ligase. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[4]  A. Casrouge,et al.  Dimerization of soluble major histocompatibility complex-peptide complexes is sufficient for activation of T cell hybridoma and induction of unresponsiveness , 1995, The Journal of experimental medicine.

[5]  N. Rosen,et al.  Herbimycin A Induces the 20 S Proteasome- and Ubiquitindependent Degradation of Receptor Tyrosine Kinases (*) , 1995, The Journal of Biological Chemistry.

[6]  T. Maniatis,et al.  Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway. , 1995, Genes & development.

[7]  M. Kirschner,et al.  Ubiquitination of the G1 cyclin Cln2p by a Cdc34p‐dependent pathway. , 1995, The EMBO journal.

[8]  J. Cambier.  New nomenclature for the Reth motif (or ARH1/TAM/ARAM/YXXL) , 1995, Immunology today.

[9]  Aaron Ciechanover,et al.  The ubiquitin-proteasome proteolytic pathway , 1994, Cell.

[10]  B. Rellahan,et al.  Transcriptional regulation of the T cell antigen receptor zeta subunit: identification of a tissue-restricted promoter , 1994, The Journal of experimental medicine.

[11]  W. Farrar,et al.  Pervanadate simulates the effects of interleukin-2 (IL-2) in human T cells and provides evidence for the activation of two distinct tyrosine kinase pathways by IL-2. , 1994, The Journal of biological chemistry.

[12]  L. Staszewski,et al.  Ubiquitin-dependent c-Jun degradation in vivo is mediated by the δ domain , 1994, Cell.

[13]  A. Weissman,et al.  The T-cell antigen receptor: a multisubunit signaling complex. , 1994, Chemical immunology.

[14]  J. P. Jensen,et al.  Activation-dependent ubiquitination of a T cell antigen receptor subunit on multiple intracellular lysines. , 1994, The Journal of biological chemistry.

[15]  A. Veillette,et al.  Tyrosine protein kinases in T lymphocytes. , 1994, Chemical immunology.

[16]  P. Auberger,et al.  Induction of tyrosine phosphorylation and T-cell activation by vanadate peroxide, an inhibitor of protein tyrosine phosphatases. , 1994, The Biochemical journal.

[17]  I. Trowbridge,et al.  CD45: an emerging role as a protein tyrosine phosphatase required for lymphocyte activation and development. , 1994, Annual review of immunology.

[18]  A. Gotoh,et al.  Ligand-dependent polyubiquitination of c-kit gene product: a possible mechanism of receptor down modulation in M07e cells. , 1994, Blood.

[19]  A. Weiss.  T cell antigen receptor signal transduction: A tale of tails and cytoplasmic protein-tyrosine kinases , 1993, Cell.

[20]  R. Abraham,et al.  Stimulatory effects of the protein tyrosine phosphatase inhibitor, pervanadate, on T-cell activation events. , 1993, The Journal of biological chemistry.

[21]  J. Kinet,et al.  Cell surface control of the multiubiquitination and deubiquitination of high‐affinity immunoglobulin E receptors. , 1993, The EMBO journal.

[22]  C. Heldin,et al.  Ligand-induced ubiquitination of the platelet-derived growth factor beta-receptor plays a negative regulatory role in its mitogenic signaling. , 1993, The Journal of biological chemistry.

[23]  J. O’Shea,et al.  Activation of human peripheral blood T lymphocytes by pharmacological induction of protein-tyrosine phosphorylation. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[24]  C. June,et al.  The protein tyrosine kinase inhibitor herbimycin A, but not genistein, specifically inhibits signal transduction by the T cell antigen receptor. , 1992, International immunology.

[25]  H. Metzger,et al.  Transmembrane signaling: the joy of aggregation. , 1992, Journal of immunology.

[26]  C. June,et al.  The CD45 tyrosine phosphatase regulates phosphotyrosine homeostasis and its loss reveals a novel pattern of late T cell receptor-induced Ca2+ oscillations , 1992, The Journal of experimental medicine.

[27]  Arthur Weiss,et al.  Genetic evidence for the involvement of the lck tyrosine kinase in signal transduction through the T cell antigen receptor , 1992, Cell.

[28]  A. Weiss,et al.  Restoration of T cell receptor-mediated signal transduction by transfection of CD45 cDNA into a CD45-deficient variant of the Jurkat T cell line. , 1992, Journal of immunology.

[29]  V. Fried,et al.  Activation-induced ubiquitination of the T cell antigen receptor. , 1992, Science.

[30]  P. Chock,et al.  Protein ubiquitination is regulated by phosphorylation. An in vitro study. , 1992, The Journal of biological chemistry.

[31]  J. Ashwell,et al.  Mutagenesis of T cell antigen receptor zeta chain tyrosine residues. Effects on tyrosine phosphorylation and lymphokine production. , 1992, The Journal of biological chemistry.

[32]  A. Kong,et al.  A tyrosine-phosphorylated 70-kDa protein binds a photoaffinity analogue of ATP and associates with both the zeta chain and CD3 components of the activated T cell antigen receptor. , 1992, The Journal of biological chemistry.

[33]  A. Varshavsky.  The N-end rule , 1992, Cell.

[34]  C. Heldin,et al.  Ligand-induced polyubiquitination of the platelet-derived growth factor beta-receptor. , 1992, The Journal of biological chemistry.

[35]  E. Reinherz,et al.  Phosphorylation of multiple CD3 zeta tyrosine residues leads to formation of pp21 in vitro and in vivo. Structural changes upon T cell receptor stimulation. , 1992, The Journal of biological chemistry.

[36]  S. Jentsch.  The ubiquitin-conjugation system. , 1992, Annual review of genetics.

[37]  M. Rechsteiner.  Natural substrates of the Ubiquitin proteolytic pathway , 1991, Cell.

[38]  A. Murray,et al.  Cyclin is degraded by the ubiquitin pathway , 1991, Nature.

[39]  A. Weiss,et al.  Tyrosine phosphatase CD45 is essential for coupling T-cell antigen receptor to the phosphatidyl inositol pathway , 1990, Nature.

[40]  R. Klausner,et al.  Association of the fyn protein-tyrosine kinase with the T-cell antigen receptor. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[41]  Matthew L. Thomas,et al.  Evidence that the leukocyte-common antigen is required for antigen-induced T lymphocyte proliferation , 1989, Cell.

[42]  R. Klausner,et al.  Biochemical characterization of the eta chain of the T-cell receptor. A unique subunit related to zeta. , 1989, The Journal of biological chemistry.

[43]  R. Klausner,et al.  The T cell antigen receptor zeta chain is tyrosine phosphorylated upon activation. , 1988, The Journal of biological chemistry.

[44]  B. Alarcón,et al.  Familial defect in the surface expression of the T-cell receptor-CD3 complex. , 1988, The New England journal of medicine.

[45]  R. Klausner,et al.  Internalization and cycling of the T cell antigen receptor. Role of protein kinase C. , 1987, The Journal of biological chemistry.

[46]  M. Crumpton,et al.  The human T3 gamma chain is phosphorylated at serine 126 in response to T lymphocyte activation. , 1987, The Journal of biological chemistry.

[47]  M. Krangel.  Endocytosis and recycling of the T3-T cell receptor complex. The role of T3 phosphorylation , 1987, The Journal of experimental medicine.

[48]  R. Klausner,et al.  A new subunit of the human T-cell antigen receptor complex , 1986, Nature.

[49]  M. Crumpton,et al.  Activators of protein kinase C down-regulate and phosphorylate the T3/T-cell antigen receptor complex of human T lymphocytes. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[50]  A. Weiss,et al.  Requirement for the coexpression of T3 and the T cell antigen receptor on a malignant human T cell line , 1984, The Journal of experimental medicine.

[51]  A. Weiss,et al.  Role of T3 surface molecules in human T-cell activation: T3-dependent activation results in an increase in cytoplasmic free calcium. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[52]  R. Germain,et al.  Monoclonal antibodies against the antigen receptor on a cloned T-cell hybrid. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[53]  E. Reinherz,et al.  Clonotypic structures involved in antigen-specific human T cell function. Relationship to the T3 molecular complex , 1983, The Journal of experimental medicine.